David Trick
Analyst · BTIG. Please proceed with your question
Thank you, Claude and good morning to everyone. During the second quarter of 2019, Ambac incurred a net loss of $128 million or $2.79 per diluted share compared to a net loss of $43.2 million or $0.94 per diluted share in the first quarter of 2019. As Claude discussed the main driver of second quarter results was the execution of the Ballantyne restructuring and commutation, which resulted in a GAAP net loss of $83 million. The loss was a result of accelerated amortization of the insurance intangible assets. In addition to the impact of Ballantyne, second quarter results were impacted by net positive development from loss and loss expenses at a higher net loss on derivative contracts compared to the first quarter of 2019. Adjusted earnings for the second quarter were $86 million or $1.88 per diluted share compared to an adjusted loss of $9 million or $0.20 per diluted share in the first quarter. Adjusted earnings were driven by $119 million gain from the Ballantyne commutation, the primary difference between the adjusted earnings from GAAP earnings being the exclusion of the insurance intangible assets amortization expense. Notable items the second quarter include premiums earned of $8 million versus $28 million during the first quarter, while normal earned premium only decreased by about $2 million to $14 million due to the continued reduction of the insured portfolio. Accelerated premiums declined $18 billion from the first quarter. The swing in the accelerated premium was mostly a result of $6 million of negative accelerated premiums realized in the second quarter driven by the Ballantyne commutation compared to $12 million positive accelerated premium realized in the first quarter mostly related to the COFINA transaction. Investment income for the second quarter was $86 million, a $32 million increase from $55 million for the first quarter of 2019. The increase in net investment income for the second quarter was due to accelerated discount on approximately $153 million share value of Ballantyne bonds held in the investment portfolio. Net realized investment gains were $36 million for the second quarter. The principal source of these gains was foreign exchange gains related to the Ballantyne restructuring and gains from sales of new COFINA bonds. Proceeds from the sale of new COFINA bonds at AAC and other cash have and continue to be redeployed into a range of other investments, which was designed to create greater diversity in the portfolio and generate attractive returns to decrease our insurance and other obligations. Loss and loss expenses incurred were a benefit of $133 million in the second quarter compared to an expense of $12 million in the first quarter. The improvement was mostly due to favorable development within Ambac UK and RMBS partially offset by an increase in public finance reserves. Public finance loss and loss expenses in the second quarter were $50 million driven mostly by lower discount rates resulting from the drop in long-term interest rates. Ambac UK, another credit experienced an incurred benefit of $111 million during the second quarter primarily as a result of the Ballantyne commutation. RMBS and student loans combined produced an incurred benefit of $73 million driven by the impact of lower interest rates on excess spread and a $19 million recovery from the settlement of an Article 77 RMBS proceeding that we have not previously accrued for. Net losses on derivative contracts were $35 million for the second quarter compared to $16 million for the first quarter attributable in both periods to declines in forward interest rates. Interest rate derivative losses in the second quarter were more than offset by approximately $96 million of gains recognized in the insured and investment portfolios driven by forward interest rate movements. Turning to expenses, second quarter operating expenses were $29 million, an increase of $4 million from the first quarter. The main driver of the increase was higher performance-based deferred compensation payable primarily to Ambac UK employees triggered by the close of the Ballantyne commutation. Non-compensation expenses were $11.6 million for the second quarter, up $1.3 million from $10.3 million in the first quarter driven by consulting and legal fees. While expenses increased this quarter, the increase is mostly a function of our successes related to the de-risking of the insured portfolio, which created significant value for stakeholders. That said, we remained focused on reducing our core operating expenses and note a few key successes this quarter towards this objective, including changes to our RMBS analytics platform, which beginning in the second quarter will reduce annual expenses by $1 million. Scheduled personnel consultant reductions beginning in the fourth quarter related to the Ballantyne commutation and general risk reduction in Ambac UK which will reduce annual operating expenses by over $1.2 million when fully implemented. This aside, we do expect volatility quarter-to-quarter for expenses given the nature of our operations. Insurance intangible amortization for the second quarter of 2019 increased $190 million to $226 million, with $36 million in the first quarter of 2019. As noted earlier, this increase was due to the accelerated amortization recognized as a result of the Ballantyne commutation. Provision for income taxes in the second quarter was $28 million, $26 million higher than the provision for the first quarter of 2019. The second quarter tax expense was related primarily to foreign income taxes on the gains from the Ballantyne commutation. Turning now to the balance sheet, shareholders’ equity decreased $2.85 per share from March 31, 2019 to $32.78 per share on June 30, 2019 due mostly to the net loss for the quarter. Adjusted book values increased to $1.35 billion at June 30, 2019 from $1.25 billion at March 31, 2019 primarily driven by second quarter adjusted earnings. Adjusted book value on a per share basis increased by $2.05 to $29.57 per share at June 30, 2019. On a standalone basis, as of June 30, 2019, AFG held cash investments and receivables of approximately $469 million or $10.30 per share. That concludes my formal remarks. I will now turn the call back to Claude for some closing remarks.